Suma Krishnan sold $2.1M of KRYS
President, R&D at Krystal Biotech, Inc.. 14,127 shares at an average of $150.27, traded Jul 9, 2025, filed Jul 11, 2025.
Score components
- +20RolePresident
- +25Trade size$2.1M at market
- 0Share of holdings soldSold 1.0% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001298711-25-000007, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 9, 2025 | SOpen-market sale Common Stock10b5-1 | -200 | $150.14 | $30k | 1,463,511 | Jul 11, 2025 |
| Jul 10, 2025 | SOpen-market sale Common Stock10b5-1 | -6,500 | $150.23 | $976k | 1,457,011 | Jul 11, 2025 |
| Jul 10, 2025 | SOpen-market sale Common Stock10b5-1 | -300 | $151.39 | $45k | 1,456,711 | Jul 11, 2025 |
| Jul 9, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -200 | $150.07 | $30k | 1,532,856 | Jul 11, 2025 |
| Jul 10, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -6,627 | $150.22 | $995k | 1,526,229 | Jul 11, 2025 |
| Jul 10, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -300 | $151.39 | $45k | 1,525,929 | Jul 11, 2025 |
Related signals
Other insiders at Krystal Biotech, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $9.0M 25,000 shares | -2% | |
| 33Weak | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $9.0M 25,000 shares | -2% | |
| 38Weak | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $11M 50,000 shares | -3% | |
| 33Weak | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $11M 50,000 shares | -3% | |
| 38Weak | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $5.4M 35,873 shares | -2% | |
| 33Weak | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $5.4M 35,873 shares | -2% | |
| 38Weak | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $2.1M 14,127 shares | -1% | |
| 45Moderate | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $8.9M 50,000 shares | -3% | |
| 40Moderate | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $8.9M 50,000 shares | -3% | |
| 6Weak | Krystal Biotech, Inc. | Kathryn Romano Chief Accounting Officer | $131k 750 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.